- All sections
- C - Chemistry; metallurgy
- C12N - Microorganisms or enzymes; compositions thereof; propagating, preserving, or maintaining microorganisms; mutation or genetic engineering; culture media
- C12N 9/42 - Hydrolases (3.) acting on glycosyl compounds (3.2) acting on beta-1, 4-glucosidic bonds, e.g. cellulase
Patent holdings for IPC class C12N 9/42
Total number of patents in this class: 1750
10-year publication summary
|
198
|
169
|
159
|
136
|
170
|
90
|
95
|
65
|
57
|
19
|
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Novozymes A/S | 3314 |
213 |
| Novozymes, Inc. | 317 |
162 |
| IFP Energies Nouvelles | 2717 |
64 |
| Danisco US Inc. | 1045 |
54 |
| DSM IP Assets B.V. | 5856 |
46 |
| Codexis, Inc. | 776 |
37 |
| Modernatx, Inc. | 1181 |
28 |
| Toray Industries, Inc. | 6652 |
27 |
| Iogen Energy Corporation | 100 |
27 |
| AB Enzymes Oy | 69 |
24 |
| Kao Corporation | 4843 |
23 |
| The Regents of the University of California | 18943 |
21 |
| Clariant Produkte (Deutschland) GmbH | 354 |
18 |
| ROAL Oy | 49 |
18 |
| Honda Motor Co., Ltd. | 24537 |
16 |
| Proteus | 25 |
16 |
| Versalis S.P.A. | 511 |
16 |
| Takeda Pharmaceutical Company Limited | 2961 |
15 |
| BP Corporation North America Inc. | 776 |
14 |
| Lallemand Hungary Liquidity Management LLC | 111 |
14 |
| Other owners | 897 |